Acquisition will give Clinigen expanded capabilities to help its clients navigate the complexities of pharmaceutical development and commercialisation. LONDON, UK, 6 August 2024 – Clinigen, a global leader in specialist pharmaceutical services committed to ethical access to medicines, today announces

Thank you for attending our recent webinar on ‘Insights into Scientific Advice in Europe’. Would you like your copy? The recording of the webinar is now available to download, please email Reha Joshi at rjoshi@kinesysconsulting.com to request a copy of

Would you like to speak to our regulatory affairs experts without having to worry about commitment, obligation or contracts?  The regulatory team at Kinesys Consulting will provide you with up to 30 minutes of complimentary consultation to help you decide

Kinesys is very pleased to announce that our long-term client Soligenix, Inc. has been granted an ILAP ‘Innovation Passport’ by UK MHRA for the company’s novel HyBryte treatment for Cutaneous T-Cell Lymphoma (CTCL). We are delighted to have supported Soligenix,